- DRRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
DURECT (DRRX) 8-K25 Sep 24DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated HepatitisFinancial data
Company Profile